À¦°óSMÉçÇø

Daria Trojan, MD

Daria Trojan, MD
Contact Information
Phone: 
514-398-8911
Email address: 
daria.trojan [at] mcgill.ca
Hospital title: 
Associate Professor in the Department of Neurology and Neurosurgery
Location: 
Post-Polio Clinic
Biography: 

Dr. Daria Trojan is an Associate Professor in the Department of Neurology and Neurosurgery at À¦°óSMÉçÇø and Professeure associée of Medicine at the Université de Montréal.  Dr. Trojan is a physiatrist at the Montreal Neurological Hospital (MNH), Jewish Rehabilitation Hospital, and the Lethbridge-Layton-MacKayÌý Rehabilitation Centre-Constance-Lethbridge site. Dr. Trojan specializes in post-polio syndrome and other neuromuscular diseases and disorders.  She coordinates the Post-Polio Clinic at the MNH and Lethbridge-Layton-Mackay Rehabilitation Centre. She is a clinical researcher in the area of the late effects of polio and sleep abnormalities in multiple sclerosis.Ìý

Dr. Trojan obtained her B.A. (Chemistry) from Swarthmore College, PA in 1980 and her M.D. from the University of Connecticut School of Medicine in 1984.  Dr. Trojan conducted her postgraduate residency training at Columbia –Presbyterian Medical Center (Columbia University), University Hospital (Boston University) and Montreal General Hospital (À¦°óSMÉçÇø).  Dr. Trojan completed a M.Sc. (Epidemiology and Biostatistics) at À¦°óSMÉçÇø (1993).Ìý

Dr. Trojan has won awards and honours including Fellowships and Clinical Research Scholarships from the Fonds de la recherche en Santé du Québec.Ìý

Selected publications: 

Fordyce CB. Gagne D, Jalili F, Alatab S, Arnold DL, Da Costa D, Sawoczczuk S, Bodner C, Shapiro S, Collet J-P, Le Cruguel J-P, Robinson A, Lapierre Y, Bar-Or A, Trojan DA. Elevated serum inflammatory markers in post-poliomyelitis syndrome. Journal of the Neurological Sciences 2008;271:80-86.ÌýÌýÌý

Trojan DA, Arnold D, Collet J-P, Shapiro S, Bar-Or A, Robinson A, Le Cruguel J-P, Ducruet T, Narayanan S, *Arcelin K, Tartaglia MC, Caramanos Z, Da Costa D. Fatigue in PPS: association with disease-related, behavioral, and psychosocial factors. Physical Medicine and Rehabilitation 2009;1:442-449.Ìý

Alvarez A, Kremer R, Weiss DR, Benedetti A, Haziza M, Trojan DA. Response of postpoliomyelitis patients to bisphosphonate treatment. Physical Medicine and Rehabilitation 2010;2:1094-1103.Ìý

Trojan DA, Kaminska M, Bar-Or A, Benedetti A, Lapierre Y, Da Costa D, Robinson A, Cardoso M, Schwartzman K, Kimoff RJ. Polysomnographic measures of disturbed sleep are associated with reduced quality of life in multiple sclerosis.Ìý Journal of the Neurological Sciences 2012;316:158-63.Ìý

Coté I, Trojan DA, Kaminska M, Cardoso M, Benedetti A, Weiss D, Robinson A, Bar-Or A, Lapierre Y, Kimoff RJ. Impact of sleep disorder treatment on fatigue in multiple sclerosis. Multiple Sclerosis Journal 2013;19:480-489.ÌýÌý

Trojan DA, Narayanan S, Francis SJ, Caramanos Z, Robinson A, Cardoso M, Arnold DL. Brain volume and fatigue in patients with post-poliomyelitis syndrome. Physical Medicine and Rehabilitation 2014;6:215-220. . Ìý

Mery V, Kimoff RJ, *Suarez I, Benedetti A, Kaminska M, Robinson A, Lapierre Y, Bar-Or A, Trojan DA. High false-positive rate of questionnaire-based restless legs syndrome diagnosis in multiple sclerosis. Sleep Medicine 2015;16:877-882.ÌýÌý

Kaminska M, Browman F, Trojan DA, Genge A, Benedetti A, Petrof BJ. Feasibility of lung volume recruitment in early neuromuscular disease: a comparison between amyotrophic lateral sclerosis, myotonic dystrophy and postpolio syndrome. Physical Medicine and Rehabilitation 2015;7(7):677-684.Ìý

Gholami F, Trojan DA, Kovecses J, Haddad MN, Gholami B. A Microsoft Kinect-Based Point-of-Care Gait Assessment Framework for Multiple Sclerosis Patients. IEEE Journal of Biomedical and Health Informatics 2017;21(5):1376-85. Ìý

Khadadah S, Kimoff RJ, Duquette P, Jobin V, Lapierre Y, Benedetti A, Johara FT, Robinson A, Roger E, Bar-Or A, Leonard G, Kaminska M, Trojan DA. Effect of continuous positive airway pressure treatment of obstructive sleep apnea-hypopnea in multiple sclerosis: A randomized, double blind, placebo-controlled trial (SAMS-PAP study). Multiple Sclerosis Journal 2022;28(1):82-92.ÌýÌý

Mazerolle M, Kimoff RJ, Khadadah S, Duquette P, Jobin V, Lapierre Y, Benedetti A, Majetic K, Robinson A, Roger E, Bar-Or A, Kaminska M, Leonard G, Trojan DA. Long term effects of continuous positive airway pressure treatment of obstructive sleep apnea-hypopnea syndrome in multiple sclerosis patients. Multiple Sclerosis and Related Disorders 2024;81:105144 (doi.org/10.1016/jmsard.2023.105144).ÌýÌý

Research areas: 
Neuroimmunological Diseases

The Neuro logoÌýÀ¦°óSMÉçÇø logo

Ìý

The Neuro (Montreal Neurological Institute-Hospital)Ìýis a bilingual academic healthcare institution. We are aÌýÀ¦°óSMÉçÇø research and teaching institute; delivering high-quality patient care, as part of the Neuroscience Mission of the À¦°óSMÉçÇø Health Centre.ÌýWe areÌýproud to be a Killam Institution, supported by the Killam Trusts.

Ìý

Ìý

Back to top